Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cuprizone neurotoxicity in the rat: morphologic observations.
Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis.
A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.
Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.
Validation of the Brazilian version of the neurological fatigue index for multiple sclerosis.
Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone.
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.
Episode 34 with Dr. Jill Hollenbach on killer immunoglobulin like (KIR) receptors
Alemtuzumab improves neurological functional systems in treatment-naive relapsing-remitting multiple sclerosis patients.
The value of qualitative and quantitative assessment of lesion to cerebral cortex signal ratio on double inversion recovery sequence in the differentiation of demyelinating plaques from non-specific T2 hyperintensities.
Breastfeeding is not related to postpartum relapses in multiple sclerosis.
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.
Keystone Symposium: Viral Immunity
Biogen Data at 2016 AAN Annual Meeting Highlight Its Expansive Portfolio of MS Therapies That Meets Diverse Needs of Patients
B1 cells are unaffected by immune modulatory treatment in remitting-relapsing multiple sclerosis patients.
Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
Microglia across the lifespan: from origin to function in brain development, plasticity and cognition.
Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study.
Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2/hemoxygenase-1 pathway by altering the balance of M1/M2 macrophages.
Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
MS Frontiers 2015
Pages
« first
‹ previous
…
58
59
60
61
62
63
64
65
66
…
next ›
last »